PBA
Paradigm Biocapital Advisors’s Kura Oncology KURA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,331,321
| Closed | -$84.6M | – | 35 |
|
|
2024
Q3 | $84.6M | Sell |
4,331,321
-208,060
| -5% | -$4.07M | 2.86% | 8 |
|
|
2024
Q2 | $93.5M | Buy |
4,539,381
+1,403,994
| +45% | +$28.9M | 3.58% | 10 |
|
|
2024
Q1 | $66.9M | Buy |
3,135,387
+1,872,559
| +148% | +$39.9M | 2.35% | 20 |
|
|
2023
Q4 | $18.2M | Buy |
1,262,828
+50,000
| +4% | +$719K | 0.85% | 24 |
|
|
2023
Q3 | $11.1M | Buy |
1,212,828
+207,920
| +21% | +$1.9M | 0.75% | 27 |
|
|
2023
Q2 | $10.6M | Buy |
+1,004,908
| New | +$10.6M | 0.82% | 29 |
|